|
SLK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04240000001299E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38849999999658E-05 |
| Normal-vs-Stage2 |
1.441980E-03 |
| Normal-vs-Stage3 |
2.018500E-03 |
| Normal-vs-Stage4 |
3.385000E-04 |
| Stage1-vs-Stage2 |
5.843600E-01 |
| Stage1-vs-Stage3 |
7.328200E-01 |
| Stage1-vs-Stage4 |
4.678000E-01 |
| Stage2-vs-Stage3 |
8.015600E-01 |
| Stage2-vs-Stage4 |
7.107200E-01 |
| Stage3-vs-Stage4 |
5.792000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.16079999962815E-07 |
| Normal-vs-AfricanAmerican |
8.940700E-03 |
| Normal-vs-Asian |
2.789500E-04 |
| Caucasian-vs-AfricanAmerican |
2.380800E-01 |
| Caucasian-vs-Asian |
4.775200E-01 |
| AfricanAmerican-vs-Asian |
2.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.13920000497114E-08 |
| Normal-vs-Female |
1.960020E-01 |
| Male-vs-Female |
2.724000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.558200E-04 |
| Normal-vs-Extreme_Weight |
2.077299999792E-07 |
| Normal-vs-Obese |
4.479400E-03 |
| Normal-vs-Extreme_Obese |
5.356300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.594600E-01 |
| Normal_Weight-vs-Obese |
2.499200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.160000E-01 |
| Extreme_Weight-vs-Obese |
4.021700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.448600E-01 |
| Obese-vs-Extreme_Obese |
5.453600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.124400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.555700E-03 |
| Normal-vs-Age(61-80Yrs) |
6.39480000064196E-08 |
| Normal-vs-Age(81-100Yrs) |
3.476100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.038200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.876390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.031750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.010500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.455450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.794200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8561899999936E-05 |
| Normal-VS-Type2 PRCC |
3.12629999998926E-06 |
| Normal-VS-KIRP CIMP |
1.212320E-02 |
| Normal-VS-Unclassified PRCC |
6.671800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.834200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.873400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.075000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.253200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.366580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.503400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.5595999954613E-08 |
| Normal-vs-N1 |
4.538400E-03 |
| Normal-vs-N2 |
2.220400E-04 |
| N0-vs-N1 |
2.006200E-01 |
| N0-vs-N2 |
5.803600E-01 |
| N1-vs-N2 |
2.504400E-01 |
|
|
